ATNM — Actinium Pharmaceuticals, Inc.
—
NYSE ·
Health Care ·
Pharmaceuticals ·
CIK 1388320 ·
Last close
$1.16
Market Cap
$36.39M
52W High
$1.53
52W Low
$0.95
ADV30
218,590
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 0 | — | -5,903,000 | -5,522,000 | 45,438,000 | 42,132,000 | 43,134,000 |
| Dec 2025 | 0 | — | -6,414,000 | -5,940,000 | 51,775,000 | 47,998,000 | 43,941,000 |
| Sep 2025 | 90,000 | — | -5,692,000 | -5,131,000 | 56,151,000 | 53,391,000 | 42,367,000 |
| Jun 2025 | 0 | — | -7,503,000 | -6,878,000 | 63,017,000 | 59,928,000 | 44,004,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-24,580,000
Investing CF
$-104,000
Financing CF
$-217,000
CapEx
—
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-1.26
As of
2026-05-10
Balance + Analyst (yfinance extras)
Retained Earnings
$-409,713,000
Inventory
—
Receivables
—
ST Investments
—
EBIT TTM
$-36,247,000
Pretax Income TTM
$-33,887,000
Interest Exp TTM
—
Analysts
5
Yahoo Snapshot (yfinance, live)
Total Revenue
$90,000
EBITDA
$-25,347,000
Free Cash Flow
$-5,928,000
Enterprise Value
$-3,590,510
Total Cash
$42,132,000
Total Debt
$1,519,000
Shares Out
31,374,994
Trailing EPS
$-0.76
Book Value
$0.07
ROE
-167.7%
ROA
-28.0%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 90,000 | -36,247,000 | -33,887,000 | 51,775,000 | 43,941,000 | — | -24,580,000 |
| Dec 2024 | 0 | -42,121,000 | -38,243,000 | 76,899,000 | 44,141,000 | — | -33,072,000 |
| Dec 2023 | 81,000 | -51,920,000 | -48,818,000 | 81,445,000 | 45,066,000 | — | -47,335,000 |
| Dec 2022 | 1,030,000 | -34,104,000 | -33,017,000 | 114,192,000 | 47,711,000 | — | 8,644,000 |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$-0.48
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| RADX | Radiopharm Theranostics Ltd | $36.34M | $4.61 | — |
| GRCE | Grace Therapeutics, Inc. | $36.52M | $2.36 | — |
| LITS | Lite Strategy, Inc. | $35.73M | $1.05 | — |
| VERU | VERU INC. | $37.08M | $2.31 | — |
| SDEV | Stablecoin Development Corp | $35.52M | $1.31 | — |
News headlines (Yahoo Finance, 1h cache)
Actinium Pharmaceuticals Announces Three SNMMI 2026 Presentations Highlighting Differentiated Profile of ATNM-400 Across Lung and Prostate Cancer and Radioconjugate Optimization
2026-05-06 12:00 · Yahoo
Actinium Highlights Transcriptional Reprogramming as a Key Mechanism Underpinning Mutation-Agnostic Activity of Actimab-A in AML at the 2026 American Association of Cancer Research Annual Meeting
2026-04-22 11:00 · Yahoo
Actinium Pharmaceuticals, Inc. Announces Compelling Pan-Tumor Data for ATNM-400 Demonstrating Broad Efficacy Across Prostate, Lung, and Breast Cancer Models at the 2026 American Association of Cancer
2026-04-22 11:00 · Yahoo
Actinium Pharmaceuticals Announces New Pan-Tumor Preclinical Data for ATNM-400 in Solid Tumors and Differentiated Mechanism for Actimab-A in AML to be Presented at 2026 AACR Annual Meeting
2026-04-06 11:30 · Yahoo
Actinium Pharmaceuticals, Inc. to Present Two Abstracts at the 2026 AACR Annual Meeting
2026-02-17 12:42 · Yahoo
Are Medical Stocks Lagging Actinium Pharmaceuticals (ATNM) This Year?
2025-12-22 14:40 · Yahoo
Actinium Pharmaceuticals Presents New Preclinical Data Demonstrating Potent Anti-Tumor Activity of ATNM-400 Across Multiple Breast Cancer Subtypes Including Hormone Receptor-Positive, Triple-Negative,
2025-12-12 13:45 · Yahoo
Are Medical Stocks Lagging Alpha Cognition Inc. (ACOG) This Year?
2025-12-05 14:40 · Yahoo
Actinium Pharmaceuticals Announces ATNM-400 Data Demonstrating Potent Efficacy in Triple-Negative Breast Cancer and Ability to Overcome Endocrine and HER2-Targeted Therapy Resistance Being Presented a
2025-12-01 13:45 · Yahoo
Is Alpha Cognition Inc. (ACOG) Stock Outpacing Its Medical Peers This Year?
2025-11-19 14:41 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.